YK11

CAS No. 1370003-76-1

YK11( —— )

Catalog No. M20713 CAS No. 1370003-76-1

YK11 is an androgen receptor partial agonist that activates androgen receptor transcriptional activity in HEK293 cells overexpressing androgen receptors when used at a concentration of 0.1 μM with osteogenic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 In Stock
5MG 45 In Stock
10MG 72 In Stock
50MG 87 In Stock
100MG 110 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    YK11
  • Note
    Research use only, not for human use.
  • Brief Description
    YK11 is an androgen receptor partial agonist that activates androgen receptor transcriptional activity in HEK293 cells overexpressing androgen receptors when used at a concentration of 0.1 μM with osteogenic activity.
  • Description
    YK11 is an androgen receptor partial agonist that activates androgen receptor transcriptional activity in HEK293 cells overexpressing androgen receptors when used at a concentration of 0.1 μM with osteogenic activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    Androgen Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1370003-76-1
  • Formula Weight
    430.53
  • Molecular Formula
    C25H34O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:64 mg/mL (148.65 mM)
  • SMILES
    [H][C@@]12CC[C@]3(OC(C)(OC)O\C3=C\C(=O)OC)[C@@]1(C)CC[C@]1([H])C3CCC(=O)C=C3CC[C@@]21[H]
  • Chemical Name
    methyl (E)-2-((8R9S10R13S14S17R)-2'-methoxy-2'13-dimethyl-3-oxo-123678910111213141516-tetradecahydrospiro[cyclopenta[a]phenanthrene-174'-[13]dioxolan]-5'-ylidene)acetate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kanno Y Ota R Someya K et al. Selective Androgen Receptor Modulator YK11 Regulates Myogenic Differentiation of C2C12 Myoblasts by Follistatin Expression[J]. Biological and Pharmaceutical Bulletin 2013 36(9):1460-1465.
molnova catalog
related products
  • LY2452473

    LY2452473 (TT 701;OPK 88004) is an orally bioavailable selective androgen receptor modulator (SARM) being developed for the treatment of disorders related to hypogonadism.

  • SK33

    SK33 is a potent and tissue selective anti-androgen agent. SK33 reduces androgen receptor (AR) transcriptional activity.

  • UT-155

    UT-155 is a selective and potent antagonist of the androgen receptor (AR) (Ki: 267 nM for UT-155 binding to AR-LBD).